The trial proved so successful that Bayer plans to reach out to regulators in preparation for submitting the drug candidate ...

Optimal mobile stroke unit distribution can be achieved with geospatial analysis, resulting in faster acute stroke treatment.

Donald "Frue" McAvoy and his fiancée were having a quiet day at home when his vision went black and his airway collapsed.

Stroke and heart attack are life-threatening conditions that require emergency medical attention, but they differ in the affected organ and symptoms.

Argenica Therapeutics has taken a step forward in the development of its neuroprotective drug candidate ARG-007 in acute ...

Findings are respite for German conglomerate facing sliding sales of blockbuster drugs and US legal challenges ...

The positive result in OCEANIC-STROKE means that asundexian can potentially now sit alongside prostate cancer therapy Nubeqa ...

Asundexian (Bayer) significantly reduces the risk of ischemic stroke compared with placebo, without increasing the risk of ...

ARPA-H is seeking proposals from experts in surgery, imaging and AI, including academic and scientific research institutions ...

Once-daily asundexian 50 mg, on top of antiplatelet therapy, reduced risk for recurrent ischemic stroke after a ...

Bayer has reported encouraging topline findings from its global phase 3 OCEANIC-STROKE study, evaluating the investigational ...

Imperative Care announced new real-world data evaluating ADAPT 2.0, a next-generation approach to stroke treatment.